01Pigment concentration
Localised pigment density can create stronger contrast between a marked area and the surrounding complexion.
Victoire de la Beauté · Top Innovation 2025–26RADIANCE · 02
Oral Protocol 02 · Complexion Clarity
RADIANCE
Dark spots · uneven tone · dullness
RADIANCE is a daily oral protocol for complexion clarity. It approaches visible radiance through pigment biology, cellular signalling and oxidative balance — without seeking to change the skin’s natural colour.
BELIGHT³™two randomised trials · 12 weeksHuman ingredient evidence. Not a finished-product trial of RADIANCE.
Two capsules each morning · with food · one jar = 30 days
Shipped from ParisComplimentary tracked delivery
ConciergeA person, not a form
AwardedTop Innovation 2025–26
The guided experience
See complexion in a different light.
Go deeper into the six visible veils, LumiTech 5™ and the clinical dossier behind RADIANCE.
Explore RADIANCE in depth →The RADIANCE principle
Complexion is more than colour.It is read through light.
A complexion looks clear when pigment, contrast, vascular tone and surface quality read together with less visual noise. RADIANCE is built around that more complete view of luminosity.
An optical reading of tone, not a colour-changing promise.
Why clarity can be interrupted
Six things can cloud the way skin catches light.RADIANCE looks at them together.
Uneven pigment is only one part of the picture. Oxidative stress, low-grade inflammatory signalling, microcirculation and surface contrast can all influence how even and luminous a complexion appears.
Pigment concentration
Localised pigment density can create stronger contrast between a marked area and the surrounding complexion.
01
02UV-associated unevenness
Repeated UV exposure can reinforce visible irregularity and leave light reading less evenly across the complexion.
03Post-imperfection marks
Residual post-imperfection marks can remain after a blemish has settled, leaving contrast behind.
04Oxidative haze
A diffuse oxidative haze can make the complexion look less fresh, less clear and visually less radiant.
05Signal noise
Low-grade inflammatory signalling can add instability to the way the complexion looks, even when it is subtle.
06Vascular contrast
Diffuse redness and vascular contrast can shift the way overall tone is perceived, independently of melanin.
Editorial complexion map · descriptive, not diagnostic.
Complexion is personal.
A mark, an uneven area or a persistent loss of clarity can be biologically modest and still change the way someone recognises her own face in daylight. RADIANCE keeps the mechanism precise because the experience itself is not abstract.
The aim is not a different skin colour. It is a clearer, more coherent impression of your own complexion.
The formulation architecture
LumiTech 5™Five pathways. One complexion architecture.
Five coordinated formulation pathways organise RADIANCE around pigment, redox, signal and visible contrast. Select a facet to see its role and actives. This is a formulation map — not a claim that every pathway has been clinically proven in finished RADIANCE.
01 · Tone harmonisation
01 · Tone harmonisation
Liposomal glutathione and L-cystine sit within the formula’s thiol and redox rationale for overall tone uniformity.
Liposomal glutathione · L-cystine
Formulation rationale
Patent WO2022/069416The signature active · Champagne, France
A French grape.selected over years, not seasons.
BELIGHT³™ is a patented oral complex built around selected French grape polyphenols and complementary components, chosen after extensive varietal screening.
>200 grape varieties screenedPatent WO2022/069416
≈85% tyrosinase inhibition · in vitroMechanistic result only — not a human pigmentation-reduction figure.
Two published randomised, double-blind, placebo-controlled trials · 12 weeksThe trials studied BELIGHT³™, not finished RADIANCE.
The evidence ledger
Two studies.twelve weeks. one key active.
BELIGHT³™ has been studied in two randomised, double-blind, placebo-controlled human trials focused on facial pigmentation. These data form an important part of the rationale behind RADIANCE.
2 RCTs
randomised · double-blind · placebo-controlled · 12 weeks
58 randomised · 53 completed
Healthy adults aged 45–65. At 12 weeks, facial skin-colour variables improved significantly more with BELIGHT³™ than placebo; selected dark-spot lightness measures also showed significant product effects.
Pouchieu et al. · Cosmetics 2023;10(5):14366 enrolled · 61 per protocol
Adults with facial hyperpigmentation, phototypes I–III. At week 12, selected dark-spot L* and ITA were significantly better than placebo; clinical ratings of complexion evenness and dark-spot visibility also improved.
Tursi et al. · Cosmetics 2025;12(1):27How to read the data
These clinical studies concern BELIGHT³™, one of the key complexes used in RADIANCE. They help document the ingredient rationale and the pigmentation context in which it was studied.
Customer-shared evolution
When tone looks more even,the whole face reads differently.
Small changes in contrast can change the impression of clarity across the whole complexion. Use the slider to compare the same face at day 0 and day 90.
Day 0Day 90‹›Individual result. Lighting, angle and skin condition can affect appearance. This comparison is not clinical evidence for finished RADIANCE.
You have seen the evolution
Follow RADIANCE further.
The dedicated presentation connects complexion, ingredients and evidence in one visual journey.
Explore RADIANCE in depth →The formula spectrum
Six actives.each with a reason to be there.
The formula combines six complementary actives rather than relying on one brightening story.
Pathway 02
BELIGHT³™
Champagne · FrancePatented complex centred on French grape polyphenols; signature active of the pigment pathway.
Pathway 01 · 04
Liposomal glutathione
Liposomal deliveryPlaced across tone-harmonisation and redox-support territories.
Pathway 01
L-cystine
Sulfur amino acidPaired with glutathione within the formula’s thiol and tone-harmonisation rationale.
Pathway 03
Curcumin 95%
High-purity curcuminoidsPositioned within oxidative and inflammatory-signalling context.
Se
Pathway 03 · 04
Selenium
Essential trace elementSupports endogenous antioxidant-enzyme biology and complements the redox architecture.
Pathway 05
Maritime pine
Les Landes · FrancePolyphenol-rich botanical positioned within the oxidative-stress pathway.
BioPerine® · formulation partner
Included as a formulation and absorption-support partner. No standalone “bioavailability percentage” is used here without product-specific evidence.
The ritual
Two capsules.one steady morning habit.
Take two capsules with a meal, once a day. One jar provides 30 days; 90 days is a useful reference point for assessing the routine over time.
2capsules each morning
30days per jar
90days in the reference protocol
RADIANCE complements — and does not replace — daily photoprotection and appropriate topical or medical care.
The French standard
The non-negotiables.Origin · discipline · traceability
01France
Formulated and manufactured in France.
02GMP / HACCP
Manufacturing and safety standards applied to production.
03Vegan
Plant-based HPMC capsule; no animal gelatin.
040 bulking agents
Capsule contents declared without bulking agents.
05
Top Innovation 2025–26
Top Innovation 2025–26Victoires de la Beauté distinction, presented separately from the BELIGHT³™ ingredient trials.
Scientific dossierReferences & methodology
References below document BELIGHT³™ or ingredient/mechanistic context. They do not convert ingredient studies into a finished-product RADIANCE trial.
Pouchieu C, Pourtau L, Gaudout D, et al. Cosmetics. 2023;10(5):143.
Tursi F, Pourtau L, Roveda G, et al. Cosmetics. 2025;12(1):27.
Glutathione and maritime-pine literature is contextual and ingredient-specific; outcomes cannot automatically be transferred to the finished formula.
Questions, answered
Before you begin.Clear boundaries matter.
Take two capsules each morning with food. One jar provides 30 days. The 90-day protocol is a commercial reference rhythm, while the BELIGHT³™ trials discussed on this page ran for 12 weeks. Individual response varies.
No. RADIANCE is positioned around tone uniformity, dark-spot contrast and visual clarity, not changing your natural skin colour.
The strongest human evidence presented here is for BELIGHT³™, an ingredient used in RADIANCE: two 12-week randomised, double-blind, placebo-controlled trials. These are not finished-product RADIANCE trials.
No. RADIANCE is a food supplement and is not presented as a treatment for melasma or another pigment disorder. Sudden, changing or concerning pigmentation should be assessed by a dermatologist or other qualified clinician.
Response is gradual and individual. Published BELIGHT³™ trials assessed outcomes over 12 weeks. That study horizon should not be read as a guaranteed personal timetable. Consistent photoprotection and consistent photography make changes easier to judge.
RADIANCE is formulated and manufactured in France. LumiTech 5™ organises BELIGHT³™, liposomal glutathione, L-cystine, curcumin, selenium and maritime pine, with BioPerine® as a formulation partner. The capsule is vegan and its contents are declared without bulking agents.
RADIANCE is formulated for adults. If you are pregnant or breastfeeding, taking medication, managing a medical condition or under clinical care, ask a qualified healthcare professional before use. Food supplements do not replace a varied, balanced diet.
Your skin,The SKINĒDIT protocol for a more even-looking, luminous complexion
Pigment · signal · oxidation. A 90-day complexion protocol built around LumiTech 5™ and BELIGHT³™ — designed to support clarity without changing your natural skin colour.
RADIANCE€199